COVID-19: Vaccines and Therapeutics
As part of National Minority Health Month (April), AHA shares takeaways from a conversation with the Henry Ford Health System and Islamic Center of America about their collaboration to increase COVID-19 vaccinations in the Muslim community around Detroit.
The Accelerating COVID 19 Therapeutic Interventions and Vaccines (ACTIV) initiative will enroll up to 13,500 adults aged 30 and over in a Phase 3 clinical trial to evaluate whether certain drugs approved for other conditions safely and effectively treat mild-to-moderate COVID-19, the National鈥
Atrium Health worked with partners to roll out mass vaccination events, roving units and smaller vaccination events to reduce barriers to access.
The AHA and Black Coalition against COVID April 21 at 7 p.m. ET will host a town hall on enhancing the opportunities for rural health care providers, public health organizations and rural health advocates as they advance COVID-19 prevention guidance, vaccine acceptance and vaccine administration.
The Food and Drug Administration revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.
Health care providers designated as health center 鈥渓ook-alikes鈥 by the federal Health Center Program may apply through May 14 for a portion of $145 million in grants to advance equitable access to COVID-19 vaccination, testing and treatment in underserved and vulnerable populations, the Department鈥
As we get ready to mark World Immunization Week (April 24-30), it鈥檚 an appropriate time to celebrate the incredible gift of vaccines.
MAKING IT PLAIN: Rural Hospitals and the Healthcare Delivery System flyer.
Health care providers participating in the Centers for Disease Control and Prevention鈥檚 COVID-19 Vaccination Program must administer the vaccines at no cost to recipients, the Department of Health and Human Services鈥 Office of Inspector General reminded providers and the public.
The Centers for Disease Control and Prevention鈥檚 Advisory Committee on Immunization Practices holds an emergency meeting on the Johnson & Johnson (Janssen) COVID-19 vaccine to review reports that six women aged 18-48 experienced a rare but serious condition involving blood clots and low鈥